Showing 1 - 20 results of 33 for search '"ХРОМОСОМНЫЕ БОЛЕЗНИ"', query time: 0.60s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
    Academic Journal

    Source: Сборник статей

    File Description: application/pdf

    Relation: Актуальные вопросы современной медицинской науки и здравоохранения: материалы VII Международной научно-практической конференции молодых учёных и студентов, Екатеринбург, 17-18 мая 2022 г.; http://elib.usma.ru/handle/usma/10024

  8. 8
    Academic Journal

    Source: Medical Genetics; Том 21, № 8 (2022); 35-39 ; Медицинская генетика; Том 21, № 8 (2022); 35-39 ; 2073-7998

    File Description: application/pdf

    Relation: https://www.medgen-journal.ru/jour/article/view/2129/1596; Медведев М.В. Пренатальная эхография. Дифференциальный диагноз и прогноз. 3-е изд. М.: Реал Тайм; 2012: 464.; Овсова О.В. Клинико-эпидемиологический анализ и оценка факторов риска формирования врожденных пороков развития центральной нервной системы у детей. Автореф. дисс. на соискание ученой степени к.м.н. Екатеринбург, 2007. 27 с.; Сопрунова, И.В. Клинико-эпидемиологические и профилактические аспекты врожденных пороков развития центральной нервной системы на территории Астраханской области. Дисс. на соискание ученой степени к.м.н. Саратов, 2012. 155 с.; Пренатальная Эхография. Ред. М.В. Медведев. М.: Реальное время; 2005:560.; Токтарова О.А., Терегулова Л.Е.,Абусева А.В., Вафина З.И.,Тухбатуллин М.Г. Диагностика патологии центральной нервной системы плода в рамках пренатального скрининга I триместра по модулю FMF. Практическая медицина. 2014, 3(79):128-134; Воеводин С.М., Шеманаева Т.В. Профилактика пороков развития. Медицинский Совет. 2016;(2):26-31. https://doi.org/10.21518/2079-701X-2016-2-26-31; Эсетов М.А. Ультразвуковая диагностика врожденных пороков развития плода в ранние сроки беременности. Автореф. дисс. на соискание ученой степени д.м.н. М., 2007. 41 с.; Timor-Tritch I.E., Monteagudo A., Pilu G. et al. Ultrasonography of the prenatal brain. Third edition. McGrow-Hill Companies, Inc., 2012. 490 p.; Hannon T., Tennant P.W. , Rankin J. et al. Epidemiology, natural history, progression, and postnatal outcome of severe fetal ventriculomegaly. Obstet. Gynecol. 2012; 120(6): 1345-1353. doi:10.1097/aog.0b013e3182732b53.; Козлова О.И. Нейросонография плода во втором триместре беременности. Автореф. дисс. на соискание ученой степени д.м.н.Москва, 2021. 271 с.; Корлякова М.Н, Воронин Д.В. и др. Пренатальная мультимодальная лучевая диагностика унилатеральной гипоплазии мозжечка: описание 3 случаев и обзор литературы. Пренатальная диагностика.2020;19(1):25-34.; Кондакова О.Б. Спектр наследственной патологии, характеризующейся врожденными пороками развития центральной нервной системы. Медицинская генетика. 2020;19(4):64-65. https://doi.org/10.25557/2073-7998.2020.04.64-65

  9. 9
  10. 10
  11. 11
    Academic Journal

    Source: Current Pediatrics; Том 16, № 5 (2017); 392-398 ; Вопросы современной педиатрии; Том 16, № 5 (2017); 392-398 ; 1682-5535 ; 1682-5527

    File Description: application/pdf

    Relation: https://vsp.spr-journal.ru/jour/article/view/1807/736; Bassett AS, McDonald-McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr. 2011;159(2):332–339.e1. doi:10.1016/j.jpeds.2011.02.039.; Delio M, Guo T, McDonald-McGinn DM, et al. Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes. Am J Hum Genet. 2013;92(3):439–447. doi:10.1016/j.ajhg.2013.01.018.; Scambler PJ. The 22q11 deletion syndrome. Hum Mol Genet. 2000;9(16):2421–2426. doi:10.1093/hmg/9.16.2421.; Козлова Ю.О. Разработка технологии пре- и постнатальной диагностики группы синдромов, обусловленных микроделецией 22q11.2: Автореф. дис. … канд. мед. наук. — М.; 2014. — 26 с. [Kozlova YuO. Razrabotka tekhnologii pre- i postnatal’noi diagnostiki gruppy sindromov, obuslovlennykh mikrodeletsiei 22q11.2. [dissertation abstract] Moscow; 2014. 26 p. (In Russ).]; Driscoll DA. Prenatal diagnosis of the 22q11.2 deletion syndrome. Genet Med. 2001;3(1):14–18. doi:10.109700125817-200101000-00004.; Beauchesne LM, Warnes CA, Connolly HM, et al. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol. 2005;45(4): 595–598. doi:10.1016/j.jacc.2004.10.056.; Keyte AL, Alonzo-Johnsen M, Hutson MR. Evolutionary and developmental origins of the cardiac neural crest: building a divided outflow tract. Birth Defects Res C Embryo Today. 2014;102(3): 309–323. doi:10.1002/bdrc.21076.; McElhinney DB, McDonald-McGinn D, Zackai EH, Goldmuntz E. Cardiovascular anomalies in patients diagnosed with a chromosome 22q11 deletion beyond 6 months of age. Pediatrics. 2001;108(6):e104. doi:10.1542/peds.108.6.e104.; Федеральные клинические рекомендации по диагностике и лечению синдрома делеции 22-й хромосомы. — М.: Федеральный научно-клинический центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева; 2014. — 12 с. [Federal’nye klinicheskie rekomendatsii po diagnostike i lecheniyu sindroma deletsii 22-i khromosomy. Moscow: Federal’nyi nauchnoklinicheskii tsentr detskoi gematologii, onkologii i immunologii im. Dmitriya Rogacheva; 2014. 12 p. (In Russ).]; Choi JH, Shin YL, Kim GH, et al. Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome. Horm Res. 2005;63(6):294–299. doi:10.1159/000086745.; Cheung EN, George SR, Costain GA, et al. Prevalence of hypocalcemia and its associated features in 22q11.2 deletion syndrome. Clin Endocrinol (Oxf). 2014;81(2):190–196. doi:10.1111/cen.12466.; Taylor SC, Morris G, Wilson D, et al. Hypoparathyroidism and 22q11 deletion syndrome. Arch Dis Child. 2003;88(6):520–522. doi:10.1136/adc.88.6.520.; Piliero LM, Sanford AN, McDonald-McGinn DM, et al. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood. 2004;103(3):1020–11025. doi:10.1182/blood-2003-08-2824.; Jyonouchi S, McDonald-McGinn DM, Bale S, et al. CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features. Pediatrics. 2009;12(5):e871–e877. doi:10.1542/peds.2008-3400.; Zemble R, Luning Prak E, McDonald K, et al. Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Immunol. 2010;136(3):409–418. doi:10.1016/j.clim.2010.04.011.; Greenhalgh KL, Aligianis IA, Bromilow G, et al. 22q11 deletion: a multisystem disorder requiring multidisciplinary input. Arch Dis Child. 2003;88(6):523–524. doi:10.1136/adc.88.6.523.; Digilio MC, Pacifico C, Tieri L, et al. Audiological findings in patients with microdeletion 22q11 (di George/velocardiofacial syndrome). Br J Audiol. 1999;33(5):329–333. doi:10.3109/ 03005369909090116.; Ford LC, Sulprizio SL, Rasgon BM. Otolaryngological manifestations of velocardiofacial syndrome: a retrospective review of 35 patients. Laryngoscope. 2000;110(3 Pt 1):362–367. doi:10.1097/00005537-200003000-00006.; Schneider M, Debbane M, Bassett AS, et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry. 2014;171(6): 627–639. doi:10.1176/appi.ajp.2013.13070864.; Green T, Gothelf D, Glaser B, et al. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry. 2009;48(11):1060–1068. doi:10.1097/ CHI.0b013e3181b76683.; Glaser B, Mumme DL, Blasey C, et al. Language skills in children with velocardiofacial syndrome (deletion 22q11.2). J Pediatr. 2002;140(6):753–758. doi:10.1067/mpd.2002.124774.; Gerdes M, Solot C, Wang PP, et al. Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet. 1999;85(2):127–133. doi:10.1002/(sici)1096-8628(19990716)85:23.3.co;2-6.; Mills L, Gosling A, Sell D. Extending the communication phenotype associated with 22q11.2 microdeletion syndrome. Int J Speech Lang Pathol. 2006;8(1):17–27. doi:10.1080/14417040500459650.; Kiley-Brabeck K, Sobin C. Social skills and executive function deficits in children with the 22q11 Deletion Syndrome. Appl Neuropsychol. 2006;13(4):258–268. doi:10.1207/ s15324826an1304_7.; McDonald-McGinn DM, Sullivan K. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore). 2011;90(1):1–18. doi:10.1097/ MD.0b013e3182060469.; Forbes BJ, Binenbaum G, Edmond JC, et al. Ocular findings in the chromosome 22q11.2 deletion syndrome. J AAPOS. 2007; 11(2):179–182. doi:10.1016/j.jaapos.2006.08.006.

  12. 12
  13. 13
    Academic Journal

    Source: Current Pediatrics; Том 15, № 6 (2016); 590-595 ; Вопросы современной педиатрии; Том 15, № 6 (2016); 590-595 ; 1682-5535 ; 1682-5527

    File Description: application/pdf

    Relation: https://vsp.spr-journal.ru/jour/article/view/1697/665; Botto LD, May K, Fernhoff PM, et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics. 2003;112(1 Pt 1): 101–107. doi:10.1542/peds.112.1.101.; Delio M, Guo T, McDonald-McGinn DM, et al. Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes. Am J Hum Genet. 2013;92(3):439– 447. doi:10.1016/j.ajhg.2013.01.018.; McDonald-McGinn DM, Tonnesen MK, Laufer-Cahana A, et al. Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net. Genet Med. 2001; 3(1):23–29. doi:10.109700125817-200101000-00006.; Bassett AS, McDonald-McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr. 2011;159(2):332.e331–339.e331. doi:10.1016/j.jpeds.2011.02.039.; Repetto GM, Guzman ML, Delgado I, et al. Case fatality rate and associated factors in patients with 22q11 microdeletion syndrome: a retrospective cohort study. BMJ Open. 2014;4(11):e0050415. doi:10.1136/bmjopen-2014-005041.; McDonald-McGinn DM, Minugh-Purvis N, Kirschner RE, et al. The 22q11.2 deletion in African-American patients: an underdiagnosed population? Am J Med Genet A. 2005;134(3):242–246. doi:10.1002/ajmg.a.30069.; Tenas Du Montcel S, Mendizabai H, Ayme S, et al. Prevalence of 22q11 microdeletion. J Med Genet. 1996;33(8):719. doi:10.1136/jmg.33.8.719.; sign.ac.uk [Internet]. Scottish Intercollegiate Guidelines Network. World Wide Web 2011 [cited 2016 Oct 19]. Available from: http://www.sign.ac.uk/.; Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001;323(7308):334–336. doi:10.1136/bmj.323.7308.334.; DiGeorge AM. Congenital absence of the thymus and its immunologic consequences: concurrence with congenital hypoparathyroidism. In: Bergma D, Good RA, editors. Immunologic deficiency diseases in man. New York: The National Foundation; 1968. p. 116– 121.; Scambler PJ, Carey AH, Wyse RK, et al. Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome. Genomics. 1991;10(1):201–206. doi:10.1016/0888-7543(91)90501-5.; Demczuk S, Desmaze C, Aikem M, et al. Molecular cytogenetic analysis of a series of 23 DiGeorge syndrome patients by fluorescence in situ hybridization. Ann Genet. 1994;37(2):60-65.; Gong W, Emanuel BS, Collins J, et al. A transcription map of the DiGeorge and velo- cardio-facial syndrome minimal critical region on 22q11. Hum Mol Genet. 1996;5(6):789– 800. doi:10.1093/hmg/5.6.789.; Kinouchi A, Mori K, Ando M, Takao A. Facial appearance of patients with conotruncal anomalies. Pediatr Jpn. 1976; 17(1):84–87.; Shprintzen RJ. The name game. Perspectives of the ASHA Special Interest Groups. 1998;8:7–11. doi:10.1044/ssod8.1.7.; Bailey JA, Yavor AM, Viggiano L, et al. Human-specific duplication and mosaic transcripts: the recent paralogous structure of chromosome 22. Am J Hum Genet. 2002;70(1):83–100. doi:10.1086/338458.; Babcock M, Pavlicek A, Spiteri E, et al. Shuffling of genes within low-copy repeats on 22q11 (LCR22) by Alu-mediated recombination events during evolution. Genome Res. 2003;13(12):2519–2532. doi:10.1101/gr.1549503.; Yagi H, Furutani Y, Hamada H, et al. Role of TBX1 in human del22q11.2 syndrome. Lancet. 2003;362(9393):1366–1373. doi:10.1016/S0140-6736(03)14632-6.; Guna A, Butcher NJ, Bassett AS. Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms. J Neurodev Disord. 2015;7(1):18. doi:10.1186/s11689-015-9113-x.; Zhang Z, Huynh T, Baldini A. Mesodermal expression of Tbx1 is necessary and sufficient for pharyngeal arch and cardiac outflow tract development. Development. 2006;133(18):3587–3595. doi:10.1242/dev.02539.; Papangeli I, Scambler P. The 22q11 deletion: DiGeorge and velocardiofacial syndromes and the role of TBX1. Wiley Interdiscip Rev Dev Biol. 2013;2(3):393–403. doi:10.1002/wdev.75.; Calmont A, Ivins S, Van Bueren KL, et al. Tbx1 controls cardiac neural crest cell migration during arch artery development by regulating Gbx2 expression in the pharyngeal ectoderm. Development. 2009;136(18):3173–3183. doi:10.1242/dev.028902.; Cioffi S, Martucciello S, Fulcoli FG, et al. Tbx1 regulates brain vascularization. Hum Mol Genet. 2014;23(1):78–89. doi:10.1093/hmg/ddt400.; Sellier C, Hwang VJ, Dandekar R, et al. Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11.2 deletion syndrome. PLoS ONE. 2014;9(8):e103884. doi:10.1371/journal.pone.0103884.; Guris DL, Fantes J, Tara D, et al. Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat Genet. 2001;27(3):293– 298. doi:10.1038/85855.; Racedo SE, McDonald-McGinn DM, Chung JH, et al. Mouse and human CRKL is dosage sensitive for cardiac outflow tract formation. Am J Hum Genet. 2015;96(2):235–244. doi:10.1016/j.ajhg.2014.12.025.; Bedeschi MF, Colombo L, Mari F, et al. Unmasking of a recessive SCARF2 mutation by a 22q11.12 de novo deletion in a patient with Van den Ende–Gupta syndrome. Mol Syndromol. 2010;1(5): 239–245. doi:10.1159/000328135.; Bassett AS, Caluseriu O, Weksberg R, et al. Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biol Psychiatry. 2007;61(10):1135–1140. doi:10.1016/j.biopsych.2006.07.038.; Peyvandi S, Lupo PJ, Garbarini J, et al. 22q11.2 deletions in patients with conotruncal defects: data from 1,610 consecutive cases. Pediatr Cardiol. 2013;34(7):1687–1694. doi:10.1007/s00246-013-0694-4.; Keyte AL, Alonzo-Johnsen M, Hutson MR. Evolutionary and developmental origins of the cardiac neural crest: building a divided outflow tract. Birth Defects Res C Embryo Today. 2014;102(3): 309–323. doi:10.1002/bdrc.21076.; McElhinney DB, McDonald-McGinn D, Zackai EH, Goldmuntz E. Cardiovascular anomalies in patients diagnosed with a chromosome 22q11 deletion beyond 6 months of age. Pediatrics. 2001;108(6): E104. doi:10.1542/peds.108.6.e104.; John AS, McDonald-McGinn DM, Zackai EH, Goldmuntz E. Aortic root dilation in patients with 22q11.2 deletion syndrome. Am J Med Genet A. 2009;149A(5):939–942. doi:10.1002/ajmg.a.32770.; McElhinney DB, Clark BJ, III, Weinberg PM, et al. Association of chromosome 22q11 deletion with isolated anomalies of aortic arch laterality and branching. J Am Coll Cardiol. 2001;37(8):2114–2119. doi:10.1016/S0735-1097(01)01286-4.; Федеральные клинические рекомендации по диагностике и лечению синдрома делеции 22-й хромосомы. — М.: ФНКЦ ДГОИ им. Д. Рогачева; 2014. — 12 с. [Federal’nye klinicheskie rekomendatsii po diagnostike i lecheniyu sindroma deletsii 22-i khromosomy. Moscow: FNKTs DGOI im. D. Rogacheva; 2014. 12 p. (In Russ).]; Козлова Ю.О. Разработка технологии пре- и постнатальной диагностики группы синдромов, обусловленных микроделецией 22q11.2: автореф. дис. … канд. мед. наук. — М.; 2014. — 26 с. [Kozlova YuO. Razrabotka tekhnologii pre- i postnatal’noi diagnostiki gruppy sindromov, obuslovlennykh mikrodeletsiei 22q11.2. [dissertation abstract] Moscow; 2014. 26 p. (In Russ).]; Weinzimer SA. Endocrine aspects of the 22q11.2 deletion syndrome. Genet Med. 2001;3(1):19–22. doi:10.109700125817-200101000-00005.; Garabedian M. Hypocalcemia and chromosome 22q11 microdeletion. Genet Couns. 1999;10(4):389–394.; Choi JH, Shin YL, Kim GH, et al. Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome. Horm Res. 2005; 63(6):294–299. doi:10.1159/000086745.; Cheung EN, et al. Prevalence of hypocalcemia and its associated features in 22q11.2 deletion syndrome. Clin Endocrinol (Oxf). 2014;81(2):190–196. doi:10.1111/cen.12466.; Taylor SC, Morris G, Wilson D, et al. Hypoparathyroidism and 22q11 deletion syndrome. Arch Dis Child. 2003;88(6):520–522. doi:10.1136/adc.88.6.520.; Fung WL, Butcher NJ, Costain G, et al. Practical guidelines for managing adults with 22q11.2 deletion syndrome. Genet Med. 2015;17(8):599–609. doi:10.1038/gim.2014.; Piliero LM, Sanford AN, McDonald-McGinn DM, et al. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood. 2004;103(3):1020–11025. doi:10.1182/blood-2003-08-2824.; Jyonouchi S, McDonald-McGinn DM, Bale S, et al. CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features. Pediatrics. 2009;123(5):e871– e877. doi:10.1542/peds.2008-3400.; Sullivan KE, McDonald-McGinn D, Zackai EH. CD4(+) CD25(+) T-cell production in healthy humans and in patients with thymic hypoplasia. Clin Diagn Lab Immunol. 2002;9(5):1129– 1131. doi:10.1128/CDLI.9.5.1129-1131.2002.; Zemble R, Luning Prak E, McDonald K, et al. Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Immunol. 2010;136(3):409–418. doi:10.1016/j.clim.2010.04.011.; Sullivan KE, McDonald-McGinn DM, Driscoll DA, et al. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). Arthritis Rheum. 1997;40(3):430–436. doi:10.1002/art.1780400307.; Lawrence S, McDonald-McGinn DM, Zackai E, Sullivan KE. Thrombocytopenia in patients with chromosome 22q11.2 deletion syndrome. J Pediatr. 2003;143(2):277–278. doi:10.1067/S0022-3476(03)00248-8.; Becker DB, Pilgram T, Marty-Grames L, et al. Accuracy in identification of patients with 22q11.2 deletion by likely care providers using facial photographs. Plast Reconstr Surg. 2004;114(6): 1367–1372. doi:10.1097/01.prs.0000138591.20999.f1.; Greenhalgh KL, Aligianis IA, Bromilow G, et al. 22q11 deletion: a multisystem disorder requiring multidisciplinary input. Arch Dis Child. 2003;88(6):523–524. doi:10.1136/adc.88.6.523.; Digilio MC, Pacifico C, Tieri L, et al. Audiological findings in patients with microdeletion 22q11 (di George/velocardiofacial syndrome). Br J Audiol. 1999;33(5):329–333. doi:10.3109/03005369909090116.; Ford LC, Sulprizio SL, Rasgon BM. Otolaryngological mani festations of velocardiofacial syndrome: a retrospective review of 35 patients. Laryngoscope. 2000;110(3 Pt 1):362–367. doi:10.1097/00005537-200003000-00006.; Stransky C, Basta M, McDonald-McGinn DM, et al. Perioperative risk factors in patients with 22q11.2 deletion syndrome requiring surgery for velopharyngeal dysfunction. Cleft Palate Craniofac J. 2015;52(2):183–191. doi:10.1597/13-206.; Schneider M, Debbane M, Bassett AS, et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 deletion syndrome. Am J Psychiatry. 2014;171(6):627–639. doi:10.1176/appi.ajp.2013.13070864.; Green T, Gothelf D, Glaser B, et al. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry. 2009;48(11):1060-1068. doi:10.1097/CHI.0b013e3181b76683.; Antshel KM, Fremont W, Roizen NJ, et al. ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry. 2006;45(5):596–603. doi:10.1097/01.chi.0000205703.25453.5a.; Campbell L, Swillen A. The cognitive spectrum in velo-cardiofacial syndrome. In: Murphy KC, Scramble PJ, editors. Velo-cardiofacial syndrome: a model for understanding microdeletion disorders. Cambridge, UK: Cambridge University Press; 2005. pp. 147–164. 57. Vorstman JA, Morcus ME, Duijff SN, et al. The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry. 2006;45(9): 1104–1113. doi:10.1097/01.chi.0000228131.56956.c1.; Bassett AS, Chow EW, AbdelMalik P, et al. The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry. 2003; 160(9):1580–1586. doi:10.1176/appi.ajp.160.9.1580.; Beaton EA, Simon TJ. How might stress contribute to increased risk for schizophrenia in children with chromosome 22q11.2 deletion syndrome? J Neurodev Disord. 2011;3(1):68– 75. doi:10.1007/s11689-010-9069-9.; Glaser B, Mumme DL, Blasey C, et al. Language skills in children with velocardiofacial syndrome (deletion 22q11.2). J Pediatr. 2002; 140(6):753–758. doi:10.1067/mpd.2002.124774.; Gerdes M, Solot C, Wang PP, et al. Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet. 1999;85(2):127–133. doi:10.1002/(sici)1096-8628(19990716)85:23.3.co;2-6.; Mills L, Gosling A, Sell D. Extending the communication phenotype associated with 22q11.2 microdeletion syndrome. Advances in Speech Language Pathology. 2006;8(1):17– 27. doi:10.1080/14417040500459650.; Kiley-Brabeck K, Sobin C. Social skills and executive function deficits in children with the 22q11 Deletion Syndrome. Appl Neuropsychol. 2006;13(4):258–268. doi:10.1207/s15324826an1304_7.; McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore). 2011;90(1):1–18. doi:10.1097/MD.0b013e3182060469.; Forbes BJ, Binenbaum G, Edmond JC, et al. Ocular findings in the chromosome 22q11.2 deletion syndrome. J AAPOS. 2007; 11(2):179–182. doi:10.1016/j.jaapos.2006.08.006.; Wu HY, Rusnack SL, Bellah RD, et al. Genitourinary malformations in chromosome 22q11.2 deletion. J Urol. 2002;168(6):2564–2565. doi:10.1097/01.ju.0000032176.07703.23.

  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20